Keywords: nicox, enrolls, ph, iii, naproxcinod, trial, french

NicOx enrolls Ph III naproxcinod trial

Article | 24 December 2007

Print This

French firm NicOx says it has successfully completed the enrollment of 1,020 patients in the 302 pivotal Phase III study for naproxcinod, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in